From Risk Categories to Risk-Adapted Care: Comparing the 2025 American Thyroid Association and 2024 Korean Thyroid Association Risk Stratification Systems in Differentiated Thyroid Cancer.
W. Kim, Mijin Kim
2026.6.17Endocrinology and Metabolism
Paper details
- Journal
- Endocrinology and Metabolism
- Published
- 2026.6.17
- Citations
- 0
- References
- 2
- Fields
- Medicine
Abstract
In differentiated thyroid cancer (DTC) management, initial risk stratification is a fundamental component that provides the basis for decisions regarding adjuvant therapy and follow-up intensity. The 2025 American Thyroid Association (ATA) and 2024 Korean Thyroid Association (KTA) guidelines employ recurrence risk-based stratification systems at the time of diagnosis. Although the overall framework is comparable, there exists a key structural difference: the ATA guideline adopts a four-tier system (low, low-intermediate, intermediate-high, and high risks) [1], whereas the KTA guideline maintains a three-tier sys-tem (low, intermediate, and high risks) [2,3]. This modification by the ATA may be interpreted as an effort to further refine the heterogeneous intermediate-risk group, which had been associated with a broad range of recurrence risk in previous guidelines [1,4]. These differences should not be interpreted merely as differences in classification structure, because initial risk categories may influence subsequent decisions regarding adjuvant radioactive iodine therapy, thyroid-stimulating hormone suppression, and postoperative surveillance intensity. Because many clinicians may not have the opportunity to compare both guidelines in detail, Table 1 provides a side-by-side summary of the major category-defining differences be-tween the 2024 KTA and 2025 ATA
Citation format
KIM, W.; KIM, Mijin. From risk categories to risk-adapted care: Comparing the 2025 american thyroid association and 2024 korean thyroid association risk stratification systems in differentiated thyroid cancer. Endocrinology and Metabolism, 2026, 41(3): 383–386.